We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Evaluation of Rapid Rabies Tests Reveals Problems with Accuracy

By LabMedica International staff writers
Posted on 06 Jul 2016
If humans bitten by a rabid animal are treated quickly, the disease can usually be prevented but such post-exposure prophylaxis is expensive and should be reserved for bites from animals with confirmed infection, but testing dogs for rabies in resource-poor settings is challenging.

The gold standard for rabies diagnosis is the fluorescence antibody test (FAT), which requires that brain tissue is fixed on microscope slides, stained with fluorescently labelled antibodies, and examined under a fluorescence microscope. More...
Alternative diagnostics include various assays to detect virus, antigen or viral ribonucleic acid (RNA), the latter based on polymerase chain reaction (PCR) technology. All of these tests require laboratory equipment, trained staff, and temperature-sensitive reagents.

Scientists at the Friedrich-Loeffler-Institute (Greifswald-Insel Riems, Germany) and their international colleagues compared six commercial lateral flow devices (LFD) for the diagnosis of rabies and their analytical sensitivity. They examined the sensitivity of the tests, their ability to exclude rabies infection accurately, as well as their specificity, which reflects an accurate positive diagnosis, in comparison with fluorescent antibody tests (FAT) and PCR in over 100 samples from experimentally infected animals and animals infected in the wild.

The investigators found that while all six tests showed good specificity, that is none gave false positives, they found that none of them demonstrated good sensitivity across the different sample sets. In fact, more than half of all positive samples, those with positive FAT and PCR results yielded "false negative" LFD results. Some LFD tests did better than others, and in some cases specific batches of the same test did better than others, but overall the results were disappointing.

The Antigen Rapid Rabies Ag-Test (Bionote Inc, Hwaseong-si, South Korea) displayed a positive rate for seven samples; the Rabies Virus Ag Rapid Test (Green Springs, Shenzhen, China) for 10 samples; the Rapid Rabies Ag Test (Creative Diagnostics, Shirley, NY, USA) for 14 samples. The scientists did report that viral RNA can be stored and eventually extracted from the LFDs using standard procedures available at molecular diagnostic laboratories. In fact, they were able to detect viral RNA after six weeks of storage at room temperature.

The authors concluded that with their current limitations commercially available rabies LFDs cannot be recommended for routine diagnosis and surveillance. If animals were involved in a biting incident to a human being, they note that false negative results may induce the patient and the doctor to refrain from appropriate post-exposure prophylaxis (PEP) given its high cost, even if the leaflet accompanying the test states that results are to be confirmed by a reference method. The study was published on June 23, 2016, in the journal PLOS Neglected Tropical Diseases.

Related Links:
Friedrich-Loeffler-Institute
Bionote
Green Springs
Creative Diagnostics

New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.